Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Murphy

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Molecular Cancer Therapeutics|August 10, 2019
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human <i>PD-1xLAG-3</i>-Knockin MiceElena Burova, Aynur Hermann, Jie Dai, et al.
The ISME Journal|January 27, 2023
Ubiquitous occurrence of a dimethylsulfoniopropionate ABC transporter in abundant marine bacteriaChun-Yang Li, Michaela A Mausz, Andrew Murphy, et al.
Journal of Lipid Research|September 10, 2020
Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in bloodRyunosuke Ohkawa, Hann Low, Nigora Mukhamedova, et al.
The American Journal of Cardiology|July 19, 2025
Vitamin K Antagonists Versus Direct Oral Anticoagulation After Transcatheter Mitral Valve ReplacementMaja Wichhart Donzo, Elsa Hebbo, Hiroki A Ueyama, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitorCarolyn Jablonowski, Waise Quarni, Shivendra Singh, et al.
Cancer Research|November 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or SomatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Molecular and Cellular Biology|October 10, 2007
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylationDavid B Lombard, Frederick W Alt, Hwei-Ling Cheng, et al.
Science Advances|April 14, 2023
IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver modelsMarisa Carbonaro, Kehui Wang, Hui Huang, et al.
Elife|March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitorCarolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|August 10, 2019
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human <i>PD-1xLAG-3</i>-Knockin MiceElena Burova, Aynur Hermann, Jie Dai, et al.
The ISME Journal|January 27, 2023
Ubiquitous occurrence of a dimethylsulfoniopropionate ABC transporter in abundant marine bacteriaChun-Yang Li, Michaela A Mausz, Andrew Murphy, et al.
Journal of Lipid Research|September 10, 2020
Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in bloodRyunosuke Ohkawa, Hann Low, Nigora Mukhamedova, et al.
The American Journal of Cardiology|July 19, 2025
Vitamin K Antagonists Versus Direct Oral Anticoagulation After Transcatheter Mitral Valve ReplacementMaja Wichhart Donzo, Elsa Hebbo, Hiroki A Ueyama, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitorCarolyn Jablonowski, Waise Quarni, Shivendra Singh, et al.
Cancer Research|November 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or SomatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Molecular and Cellular Biology|October 10, 2007
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylationDavid B Lombard, Frederick W Alt, Hwei-Ling Cheng, et al.
Science Advances|April 14, 2023
IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver modelsMarisa Carbonaro, Kehui Wang, Hui Huang, et al.
Elife|March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitorCarolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Pageof 16